The cells are implicated in a wide range of human lung diseases, including asthma, pulmonary hypertension, cystic fibrosis and sudden infant death syndrome, among others.
research
Urban Canid Project helps track Madison’s coyotes and prevent conflicts
Since 2014, the Urban Canid Project has heavily emphasized outreach and public engagement in the study of Madison’s foxes and coyotes. So far, its efforts have met success.
Antibody targets key cancer marker; opens door to better diagnosis, therapy
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine. In mouse models of human brain cancer, their tag is easily seen in a PET scanner, which is commonly used to detect cancer.
UW neuroscientists describe brain chemicals that create PTSD response
A new study by University of Wisconsin-Madison neuroscientists shows how stress chemicals reshape the brains of rodents, research that could lead to better treatments for people with post-traumatic stress disorder (PTSD).
Drug protects fertility and may prolong life in chemo-treated mice
A University of Wisconsin-Madison physician and her research team have shown that a heart medication can prevent ovarian damage and improve survival in adolescent mice after chemotherapy. The treatment also increased the number of their healthy offspring.
Ned Kalin wins Anna-Monika Prize for neuroscience research
Ned Kalin, chair of psychiatry at the UW School of Medicine and Public Health, will receive a major award this week at a conference in Amsterdam for his work in uncovering the signature of anxiety and depression in the brain.
Flu study, on hold, yields new vaccine technology
Vaccines to protect against an avian influenza pandemic as well as seasonal flu may be mass produced more quickly and efficiently using technology described today (Sept. 2) by researchers at the University of Wisconsin-Madison in the journal Nature Communications.
Apes may be closer to speaking than many scientists think
Koko the gorilla is best known for a lifelong study to teach her a silent form of communication, American Sign Language. But some of the simple sounds she has learned may change the perception that humans are the only primates with the capacity for speech.
Cancer discovery links experimental vaccine and biological treatment
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Ebola whole virus vaccine shown effective, safe in primates
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.